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Pathophysiology of contrast medium–induced nephropathy.
Background. Contrast medium–induced nephropathy (CIN)
is a well-known cause of acute renal failure, but the develop-
ment of CIN remains poorly understood. A number of studies
have been performed with the one aim, to shed some light onto
the pathophysiology of CIN. These have led to manifold inter-
pretations and sometimes contradicting conclusions.
Methods. This review critically surveys mechanisms believed
to mediate CIN by highlighting the complex pathophysiologic
entity, including altered rheologic properties, perturbation of
renal hemodynamics, regional hypoxia, auto- and paracrine
factors [adenosine, endothelin, and reactive oxygen species
(ROS)], and direct cytotoxic effects. Moreover, the importance
of physicochemical properties of contrast media are made clear.
Results. The more recently developed iso-osmolar contrast
media are dimers, not monomers as the widely used nonionic
low osmolar contrast media. The dimers have physicochemical
features different from other contrast media which may be of
clinical importance, not only with respect to osmolality. The
viscosity of the commercially available dimers is considerably
higher than blood.
Conclusion. Many experimental studies provide evidence for
a greater perturbation in renal functions by dimeric contrast
media in comparison to nonionic monomeric contrast media.
Clinical trials have yielded conflicting results.
Interventional techniques, fast multislice computer to-
mographies (CTs) and new three-dimensional recon-
struction techniques have increased the use of iodinated
intravascular contrast media over the last decades. Today,
approximately 60 million doses are applied per year. Al-
though new techniques such as magnetic resonance imag-
ing (MRI) and ultrasound have been introduced, and the
hazard of x-ray radiation is evident, the majority of ex-
aminations require iodinated contrast media for accurate
and safe diagnosis and interventional procedures.
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This article is aimed at reviewing the mechanisms un-
derlying contrast medium–induced nephropathy (CIN).
The term CIN implies impairment in renal function
occurring within 3 days following the intravascular ad-
ministration of contrast medium and the absence of an
alternative etiology [1, 2]. An increase in serum creatinine
by more than 25% or 44 lmol/L−1 (0.5 mg/100 mL) within
48 to 72 hours of contrast administration is often taken
as a marker for the occurrence of CIN [3–6]. The serum
creatinine concentration typically peaks on the second or
third day after exposure to contrast medium and usually
returns to the baseline value within 2 weeks [7, 8].
Since the 1950s, the various available contrast me-
dia have been based on triiodobenzene. They are
commonly grouped according to their osmolality and
ionicity. In the era when high-osmolar contrast media
(having osmolalities approximately six times higher than
the plasma) were widely used, the differentiation with
regard to osmolality made sense, although it has become
clear that many of the side effects were caused by the
electric charge. Today, only the low-osmolar contrast me-
dia (which still have considerably higher osmolality than
plasma) and iso-osmolar contrast media are widespread.
It appears that the subdivision of contrast media accord-
ing to their osmolality may require reconsideration, since
iso-osmolar contrast media are dimers. The currently
available dimeric contrast media reveal greater viscosities
than the monomeric low-osmolar contrast media (Fig. 1).
This can have important implications for renal and sys-
temic hemodynamics as outlined below.
PATHOPHYSIOLOGY OF CIN
The underlying mechanism to CIN is not clear, though
several suggestions have been put forward. Most likely, a
combination of various mechanisms are responsible for
the development of CIN [9]. A reduction in renal perfu-
sion caused by a direct effect of contrast media on the
kidney and toxic effects on the tubular cells are generally
accepted as the main factors in the pathophysiology of
CIN. However, the pathophysiologic relevance of direct
effects of contrast media on tubular cells is contentious
[9], as are the other proposed etiologies.
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Fig. 1. Osmolality and viscosity for I-concentration of 300 mg/mL.
Blood viscosity refers to prearteriolar values. Viscosity and osmolality
values taken from information provided by the respective distributor.
∗In case of Iodixanol the viscosity value for 300 mg I/mL was extrapo-
lated from the values of the 150, 270, and 320 mg I/mL solutions. The
osmolality of Iodixanol is constant for all three concentrations.
Among the discussed mechanisms behind CIN that
will be outlined here are rheologic alterations, activation
of the tubuloglomerular feedback response, regional hy-
poxia, cytotoxic effects on the renal epithelial cells, gen-
eration of reactive oxygen species (ROS), and, finally,
increased adenosine or endothelin production.
Rheology
One of the particularities of the renal vascular bed is
the length of the vessels that supply the renal medulla with
blood. These vasa recta have the same diameter as usual
capillaries, but they are severalfold longer than average
capillary vessels, meaning that vascular resistance is high.
To offset the increased resistance caused by the vessel
length, the viscosity of the blood flowing through the vasa
recta is maintained very low. This is due to two effects.
First, as with all capillaries, the blood flowing through
these vessels has a low hematocrit since the erythrocytes
have higher flow velocities (Fa˚hraeus-Lindqvist effect).
Thus, blood viscosity in the capillary is not much higher
than plasma viscosity. The second effect is that of plasma
skimming. The afferent arterioles branch off from the
interlobular arteries at an almost right angle. Since the
erythrocytes are concentrated in the center of the inter-
lobular arteries (laminar flow), the plasma rich blood near
the endothelium is skimmed off into the juxtamedullary
afferent arterioles.
It is often thought that iso-osmolar contrast media are
superior to low-osmolar agents, since they would not in-
crease resistance (R) to a similar extent. This is not true,
as indicated by Poiseuille’s law (equation 1). Osmolality
plays no role for blood flow while the viscous properties
(g) are decisive:
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Fig. 2. Medullary hypoxia induced by contrast media [ioxaglate (),
iopromide (), and iotrolan ()] in comparison to Ringer’s solution
(). Reduction in pO2 is greatest for iotrolan (iso-osmolal nonionic
dimer) followed by ioxaglate (low-osmolal ionic dimer). Iopromide
(low-osmolal monomer) had the least effect of the contrast media (from
Liss et al, 1998, with permission).
R = g ∗ 8 ∗ l/p ∗ r4 (Equation 1)
Thus blood flow (Q) through the vasa recta is
Q = P ∗ p ∗ r4/g ∗ 8 ∗ l (Equation 2)
where P is the pressure gradient, g is viscosity, l refers
to the length of the vessel and r is the radius.
Among the monomeric contrast media, there is a rela-
tionship between osmolarity and viscosity (Fig. 1). How-
ever, the commercially available iso-osmolar contrast
media exhibit considerably higher viscosity. Thus, iso-
osmolar contrast media should impair renal medullary
blood flow to a greater extent than low-osmolar agents.
Indeed, this seems true, as indicated by the particularly
reduced pO2 levels caused by iso-osmolar contrast media
in rats [10] (Fig. 2).
However, not only the intrinsic viscosity of the fluid
is important, but also their interaction with blood con-
stituents. For instance, high-osmolar ionic agents dimin-
ish erythrocyte deformability, thereby increasing stiffness
and making it more difficult for the red blood cells to
flow through the capillaries [11, 12]. Thus, trapping oc-
curs, meaning that the erythrocytes are densely packed
in the renal capillaries (e.g., vasa recta), and the blood
flow through these vessels may cease, as shown for the
rat [13, 14].
The adverse effects of augmented fluid viscosity by the
use of dimeric contrast media may be more pronounced
in the renal tubules than in the capillaries. Normally, the
tubular fluid has a lower viscosity than plasma, since the
ultrafiltrate contains very few plasma proteins. As seen
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Fig. 3. Flow chart of mechanisms linking fluid osmolality to renal dam-
age. GFR is glomerular filtration rate.
in the rat, use of dimeric contrast media will increase
tubular fluid viscosity thereby increasing the resistance
to flow in renal tubules [15]. Tubular viscosity will in-
crease markedly toward the distal sections of the kidney
due to fluid reabsorption. There is an exponential rela-
tionship between concentration and viscosity; thus, when
urine becomes very concentrated, tubular fluid viscosity
will increase dramatically and tubular plugging will occur.
Hydration attenuates fluid reabsorption in the collecting
ducts and is therefore very beneficial. Ueda et al [16]
measured tubular pressures after giving various contrast
media. The dimeric contrast media increased tubu-
lar pressures over the entire observation period (50
minutes) to over 40 mm Hg. Accordingly, intrarenal
interstitial pressure may significantly rise as well, thereby
impairing renal blood flow through the medulla. More-
over, such high tubular pressures as seen after the applica-
tion of dimeric contrast media will considerably diminish
glomerular filtration rate (GFR).
A scheme of the adverse effects of pronounced in-
creases in viscosity on the kidney is presented in
Figure 3. Taking these considerations into account, it is
important to note that contrast media with high viscos-
ity (i.e., dimeric iso-osmolar contrast media) should be
prewarmed before infusion, since this markedly reduces
viscosity.
The tubuloglomerular feedback
The tubuloglomerular feedback is a powerful mech-
anism in the control of renal vascular resistance and
glomerular filtration. A popular explanation for the
development of CIN is that hyperosmotic contrast
media cause diuresis, which activates the tubuloglomeru-
lar feedback and subsequently compromises renal blood
flow and glomerular filtration. However, this osmotic di-
uresis theory is not a likely explanation for CIN. The mac-
ula densa cells of the thick ascending limb sense Na+, K+,
and Cl− concentrations in the tubular fluid via the Na+-
K+-2 Cl− cotransporter. This transporter is effectively
blocked by furosemide. The affinity for Cl− is very low,
so in a physiologic setting there will always be enough
Na+ and K+ to keep the system running, Cl− is the limit-
ing factor [17, 18]. As shown already by pioneer experi-
ments with retrograde perfusions of the tubule, osmolal-
ity has no effect on the tubuloglomerular feedback. With
orthograde perfusion, quite a lot of transport occurs be-
tween tubular fluid and interstitium, and even nonionic
fluids may occasionally be able to elicit tubuloglomeru-
lar feedback response. This would leave some room for a
possible contrast media effect. In this case, however, the
CIN potential of a certain contrast media would not rely
on its osmolality, but rather on other structural features.
The ruling out of the osmotic diuresis theory is further
supported by experiments using mannitol, an osmotic di-
uretic. Increases in osmolality, such as after mannitol in-
fusion or after contrast media application, decrease NaCl
concentration at the macula densa, however, simultane-
ously increasing tubular flow. Therefore, the resulting net
change in the amount of NaCl passing the macula densa
is negligible [19].
Finally, blocking the tubuloglomerular feedback by
furosemide does not decrease serum creatinine after ap-
plication of contrast media, which is usually the param-
eter taken to indicate CIN [2]. Thus, taken together, the
theory that the osmolality of a contrast media causes CIN
via the tubuloglomerular feedback does not appear likely.
Regional hypoxia
Kidney perfusion is very high for the cortex, but the
medullary portions are maintained at the verge of hy-
poxia where pO2 levels can be as low as 20 mm Hg [20].
This is the price paid for upholding the countercurrent
mechanism for controlling urine excretion. A particu-
larly vulnerable kidney region is the deeper portion of
the outer medulla, an area remote from the vasa recta
supplying the renal medulla with blood. It is here that
the thick ascending limbs of the loop of Henle exhibit
hypoxic damage (e.g., when the kidney is perfused with
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erythrocyte-free medium) [21]. The reason for the vul-
nerability of the outer medullary portion of the nephron
is the relative high oxygen requirements due to salt
reabsorption.
Adding contrast media to the medium aggravates hy-
poxic injury to this region (Fig. 3), probably by increas-
ing renal vascular resistance, as in the rat [22]. It has
been shown also in the rat that the iso-osmolar contrast
medium, iodixanol (a dimer with high viscosity), reduces
blood flow to all regions of the kidney to a greater ex-
tent than low-osmolar, and even high-osmolar contrast
media. However, this decrease in perfusion was probably
due to profound systemic effects of iodixanol, since blood
pressure dropped considerably [23].
Iothalamate, a high-osmolar agent, markedly reduces
medullary pO2 to about a third of control levels [24]. Re-
markably, in the rat, the iso-osmolar contrast medium
iotrolan impairs local pO2 to a greater extent than the
low-osmolar contrast medium iopromide [10]. The de-
crease in pO2 by the latter failed to reach statistical sig-
nificance (Fig. 2). This underscores the shortcoming of
classifying contrast medium simply by their osmolality.
A second factor that has been thought to mediate CIN
is an increased oxygen demand due to an augmented
workload for the tubular cells. This hypothesis is not read-
ily understood, since contrast media are not reabsorbed
and bind to water, which is excreted with the contrast me-
dia. Thus, the net NaCl load remains the same. Indirectly,
however, one may be able to explain an enhanced work-
load to the tubular cells. First, there is a transient increase
in GFR after giving contrast media [25], and second, os-
motic diuresis may reduce the paracellular reabsorption
of the proximal tubule, leading to larger amounts of NaCl
having to be taken up in the more distal segments. Agmon
et al [26] have shown that contrast media can actually in-
crease medullary blood flow to the kidney, even though
pO2 decreases, which is supported also by a study of
Heyman et al [27]. These two studies indeed suggest that
an increased oxygen demand has taken place after con-
trast media application.
Local renal hypoxia can be aggravated by the systemic
effects of some contrast media, such as transiently re-
duced cardiac output [11], and suboptimal pulmonary
perfusion-ventilation relationship [28]. Moreover, oxy-
gen delivery to the peripheral tissues may be impaired,
since contrast media can increase oxygen affinity of
hemoglobin [29].
If renal outer medullary hypoxia causes CIN, block-
ing the transporters in this nephron segment should have
beneficial effects on its prevention. The bulk of trans-
port taking place in the medullary thick ascending limb
is the Na+-K+-2 Cl− transporter, which, as mentioned
above, is blocked by furosemide. Blocking the transport
would dramatically lower local oxygen consumption and
alleviate the reduced oxygen supply. In fact, this has been
demonstrated to occur in experiments in rats showing that
outer medullary pO2 is elevated after furosemide [30].
However, contrast medium injection after furosemide
still reduces outer medullary pO2 although occurring
at higher absolute pO2 values. Also in the rat model,
Heyman et al [31] were able to demonstrate an attenua-
tion of thick ascending limb damage induced by contrast
media.
Nevertheless, furosemide given to patients just before
angiography fails to limit increases in serum creatinine af-
ter contrast media application, indicating that yet other
mechanisms are involved in CIN [2]. However, atten-
tion must be paid to replenish the fluid losses induced by
furosemide, otherwise the dehydration may simply over-
ride a potential beneficial effect of furosemide.
Cytotoxic effects on renal tubular (epithelial) cells
In vitro investigations on cell lines are commonly used
for assessing renal tubular cell function or damage. A
porcine proximal tubular cell line, LLC-PK1, was used
by Hardiek et al [32] to investigate CIN. An effect on
apoptosis was not found, though, proliferation was im-
paired. Reduced proliferation will affect renal function
with a delay of hours to days, which may help explain the
clinical course of CIN. Independent of the contrast me-
dia used, tubular cell damage can occur. Vacuolization
as described by Andersen, Christensen, and Vik [33] for
isolated cells is a morphologic hallmark rather than an
indicator of damage. A more specific alteration of proxi-
mal tubular function seems to be a perturbation of mito-
chondrial enzyme activity and mitochondrial membrane
potential [32] (Fig. 4). Indeed, attenuated mitochondrial
enzyme activity is supported by the observed increase in
adenosine following application of contrast media (see
below). The extent of mitochondrial enzyme activity im-
pairment relies primarily on two features of the contrast
media: ionicity and the molecular structure. Remarkably,
low-osmolar (monomeric) contrast media had the least
effect, followed by the iso-osmolar (dimeric, nonionic)
agents. Ionic compounds revealed the most profound ef-
fects [32].
In the distal tubule, contrast media may induce apop-
tosis, as indicated in the Madin-Darby canine kidney
(MDCK) cell line model [34]. In part, this seems to rely on
hypoxic damage [35]; however, there is also a direct influ-
ence on these cells [34]. Contrast media can also open the
intercellular junctions and affect the polarity of the ep-
ithelial cell surface [36]. These features are important for
normal fluid and electrolyte reabsorption and may add to
the potential deleterious effects of contrast media.
ROS
Even under normal conditions, oxygen radicals are pro-
duced endogenously, but the levels increase during oxida-
tive stress. Among the most common oxygen radicals are
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Fig. 4. Altered mitochondrial function in a proximal tubular cell line
as determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) reduction (24-hour treatment). A comparison of the
effects of various contrast media on MTT reduction reveal significant
differences from one another. The least influence was found by the low-
osmolar agents, followed by the iso-osmolar contrast media (Iodixanol).
The ionic substances showed the greatest effect (from Hardieck et al,
2001, with permission).
superoxide (O2−), hydrogen peroxide (H2O2), and hy-
droxyl radical (OH−) [37]. Superoxide and hydroxyl rad-
ical are more reactive than H2O2, which is not a radical,
but exhibits a greater membrane permeability.
There are marked differences between the nephropa-
thy induced by streptozotocin in rats and human diabetic
nephropathy [38]. This should be kept in mind when
comparing investigations on diabetes mellitus, which is
one of the most prominent risk factors for CIN. In
diabetic nephropathy, endothelial dysfunction in renal
vessels is a common sequela. It seems that the tonic in-
fluence of nitric oxide in the renal microvasculature is
suppressed and contributes to the endothelial dysfunc-
tion in the early stages of insulin-dependent diabetes
[37]. Superoxide rapidly scavenges nitric oxide and could
therefore explain the attenuated nitric oxide activity in
the diabetic renal microvasculature. In support of this
hypothesis, superoxide production was found to be in-
creased in renal cortical tissue from diabetic rats [39].
Moreover, Ohishi and Carmines [40] demonstrated that
for juxtamedullary nephrons of streptozotocin-diabetic
rats, the afferent and efferent arteriolar vasoconstrictor
response to nitric oxide synthase (NOS) inhibition is im-
paired. Furthermore, in a recent study by Palm et al [41],
scavenger treatment (vitamin E) normalizes the reduced
pO2 found in the renal medulla of streptozotocin-diabetic
rats. Since nitric oxide inhibits oxygen consumption, it is
tempting to speculate that reduced (scavenged) nitric ox-
ide during diabetes elevates oxygen consumption thereby
leading to reduced pO2 with consequences for
endothelial-epithelial structure and function. Diabetic
nephropathy may be of importance with regard to the
conclusion of the NEPHRIC study [1] that the use of
iso-osmolar contrast media, as opposed to low-osmolar
contrast media, results in reduced incidence of CIN. The
conclusion of that study is not in line with our current
understanding of CIN and may rely on the statistically
significant difference in the duration of diabetes between
the groups.
ROS may play a role in the effects of various vaso-
constrictors that have been considered important for the
development of CIN. Since ROS are extracellular sig-
naling molecules, they may be significant in mediating
the actions of vasoconstrictors, such as angiotensin II,
thromboxane A2 (TXA2), endothelin-1, adenosine, and
norepinephrine. Moreover, various models of renal in-
flammation and ischemia have shown a role of ROS in
glomerular injury. The adverse effects of contrast media
on renal function may therefore involve the generation of
ROS (e.g., via adenosine formation). This notion is sup-
ported by experiments in which the generation of ROS
was inhibited by allopurinol, or the amount of ROS was
reduced by superoxide dismutase. In these models, con-
trast media–induced reductions in GFR are attenuated
[42]. Later studies performed in humans further under-
score a role of ROS in CIN [43].
Taking the evidence for a role of ROS in CIN into ac-
count, it is not surprising that clinical trials have been
performed with the aim to ameliorate CIN by scavenging
ROS [44–48]. In these trials, N-acetylcysteine was given in
addition to the general hydration protocols and showed a
positive outcome in four of the studies [44, 45, 47, 49] and
has therefore been recommended for the prevention of
CIN in patients with mild-to-moderate renal insufficiency
[50–52]. However, this recommendation is not unequiv-
ocal since other trials fail to confirm a positive effect [48,
53] or indicate that rigorously controlled larger trials are
still required [54].
Adenosine
Direct actions of adenosine on the renal vasculature
have been discussed with regard to CIN. In the kidney,
adenosine exerts a vasoconstrictor response of the af-
ferent arteriole, due to the predominance of A1 recep-
tors [55]. Early studies indicated the existence of both
A1 and A2A receptors in the kidney, which were found
to be widely distributed throughout the renal vascula-
ture, juxtaglomerular apparatus, glomeruli, tubules, and
collecting ducts [56, 57]. Besides its vasoconstrictor ef-
fect, A1 receptor stimulation contracts mesangial cells
in the glomerulus [58]. In 1982, Osswald, Hermes, and
Nabakowski [59] proposed that kidney hemodynamics
is under metabolic control and suggested adenosine as
the mediator of the tubuloglomerular feedback due to
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its particular vasoconstrictor response in renal circula-
tion. This hypothesis has been considerably substantiated
by experiments demonstrating lacking tubuloglomerular
feedback responses in mice devoid of adenosine A1 re-
ceptors [60–62].
Due to the prominent role of adenosine in the renal vas-
cular bed, several studies have been performed targeting
at the role of adenosine in CIN [25, 63, 64]. In diabetes
mellitus, an even higher sensitivity of the renal vascula-
ture to adenosine is found, thus, it has been suggested
that adenosine is an important contributor to CIN in
patients suffering of this metabolic disorder [65]. In spite
of the strategic role of adenosine on renal function, the
role it plays in CIN appears to be overestimated. Regard-
ing the depression in outer medullary blood flow and
oxygen tension caused by injection contrast media, the
adenosine A1 receptor is not involved, as shown in a re-
cent study in normal rat [66]. In that study, a specific A1 re-
ceptor antagonist was given together with contrast media.
Although a pronounced basal influence of A1 receptors
on renal medullary hemodynamics was confirmed, block-
ing these receptors failed to alleviate medullary hypoper-
fusion and hypoxia in response to the contrast media. In
further support of the limited role of adenosine in CIN, it
was found also that the general reduction in renal plasma
flow and GFR by contrast media is not attributable to
enhanced adenosine action [63], but rather may involve
mesangial cell contraction. However, it should be kept
in mind that the A2 receptor enhances medullary blood
flow [67] and may therefore be a potential target for pre-
venting CIN.
Endothelin
The effects of endothelin on vascular beds is very
dependent upon the receptor subtype activation. En-
dothelin (ET)-A receptor stimulation elicits pronounced
vasoconstriction, whereas the ET-B receptor has the
opposite effect. The latter likely involves endothelin-
dependent nitric oxide release. However, recently, both
subtypes of receptors were found to mediate the vasocon-
strictor action of endothelins in human blood vessels [68].
The net vasoactive response to endothelin is believed to
vary depending on the vascular bed in question.
An involvement of endothelin in CIN appears likely
due to the enhanced endothelin levels in plasma and
urine, which is observed after radiocontrast application
[69–71]. In addition, the transcription and release of en-
dothelin from endothelial cells is enhanced by contrast
media (for review see [72]). Moreover, in patients suffer-
ing of impaired renal function, the increase in endothe-
lin after giving radiocontrast is exaggerated [73]. How-
ever, the aggregate effect of endothelin in the scenario
of CIN may not be as disadvantageous as one may as-
sume from the findings mentioned above. As shown by
Wang et al [74], when both ET-A and ET-B receptors are
blocked in humans receiving contrast media, the mean
increase in serum creatinine concentration is significantly
greater in patients receiving the ET-A/ET-B blocker com-
pared with those who received placebo. Moreover, the
CIN incidence is significantly higher in patients who re-
ceive this blocker compared to placebo [74].
A potential beneficial effect of endothelin in the de-
velopment of CIN may be explained by the ET-B medi-
ated effects (e.g., vasodilatation). Accordingly, a selective
ET-A receptor blockade could prove to be effective in the
prevention of CIN. In the study of Freed et al [75] using
the unselective blocker, plasma endothelin-1 levels may
have increased as shown by a study employing a simi-
lar intravenous infusion of the same endothelin recep-
tor antagonist, SB 209670. This increase in endothelin-1
concentration is probably brought about by the ET-B re-
ceptor antagonism [76], since one of the ET-B–mediated
effects is the attenuation of further endothelin release.
Thus, the potentiation of CIN induced by SB 209670 in
the study of Wang et al could be explained by ET-B re-
ceptor blockade increasing plasma endothelin which then
acts on the ET-A receptor, as suggested by Haylor et al
[77]. Indeed, a positive effect of ET-A selective block-
ade on the renal outer medullary hypoxic response to
contrast media has been reported in the normal rat [78].
Remarkably, the hypoxia to this kidney region was alle-
viated without enhancing local blood flow. Hence, it was
concluded that the oxygen requirements must have de-
creased due to ET-A antagonism. This, in fact, may be an
important key for understanding the role of endothelin in
CIN: It appears that BQ123, a selective ET-A antagonist,
inhibits Na+/K+-ATPase activity [59, 78]. If this were to
occur in the thick ascending limbs of the loop of Henle, a
reduction in oxygen demand in the outer medulla would
be readily understood.
PREVENTION OF CIN
Unfortunately, the treatment procedures to prevent
CIN remain to be established. Several approaches of CIN
prevention have been reported, of which vigorous hy-
dration may be the most important [79, 80]. Trials us-
ing diuretics, dopamine, calcium channel blockers, atrial
natriuretic peptides, acetylcysteine, dopamine-1 receptor
agonist fenoldopam and theophyllin have yielded con-
trasting results, which have been reviewed in extent very
recently [81].
Only periprocedural hydration is widely accepted to
prevent CIN [2, 82, 83] and intravenous hydration may be
better than oral hydration. Administration of saline leads
to an isotonic hydration, thus, the fluid remains in the
extracellular space. Giving water will lead to a hypotonic
hydration, which mainly affects the intracellular space.
Orally administered saline is excreted more rapidly. This
may rely on the intestinal-renal endocrine axis for the
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maintenance of sodium balance by uroguanylin, a peptide
hormone that regulates sodium excretion by the kidney
when excess NaCl is consumed [84].
The reasons for the success of hydration in prevent-
ing CIN are not related to an increase in renal blood
flow or GFR (as sometimes thought [85]). Unless the
patient is severely dehydrated, volume loading has little
effect of these hemodynamic measures. It appears more
likely that medullary perfusion is increased when well hy-
drated (autoregulation may not be present under these
conditions [86] and suppressed vasopressin levels aug-
ment medullary blood flow [87, 88]), thus, regional pO2
is enhanced. Furthermore, the reduced concentration of
contrast medium in the tubular system of the medulla dur-
ing significant diuresis should be important and presum-
ably override any smaller differences in injected contrast
medium osmolality or viscosity.
Large clinical studies and meta analyses have indicated
that the use of low-osmolar contrast medium substan-
tially reduces the risk of nephropathy in high-risk pa-
tients as compared with the use of high-osmolar contrast
medium [4, 5, 74, 89, 90]. Nevertheless, the use for other
diagnostic techniques (i.e., MRI, ultrasound) must always
be considered. Using carbon dioxide has also been sug-
gested for replacing iodinated contrast media [91] since it
results in lower incidence of CIN. However, special equip-
ment would be required and other adverse reactions can
appear. Moreover, carbon dioxide does not provide a sim-
ilar attenuation as conventional contrast medium which
may pose a problem in situations where high contrast
properties are crucial for safe and accurate diagnosis and
interventional procedures.
CONCLUSION
There seems to be no single cause for CIN. Several
pathophysiologic mechanisms may add up to impair kid-
ney function. The use of newer contrast media and ex-
tracellular fluid volume expansion are to be preferred in
patients with preexisting renal impairments [2, 79, 92].
With regard to the current concepts to explain CIN, the
rheologic properties of a fluid may not have received suf-
ficient attention. Resistance depends on fluid viscosity,
not osmolality (Poiseuille’s law). Moreover, osmolality
does not directly affect the tubuloglomerular feedback as
already shown by the pioneer work in this field [17, 18].
Thus, perhaps too much attention has been directed to the
osmolality of different contrast media, while neglecting
the impact of other physicochemical properties. Indeed,
there is little experimental evidence that would support
the notion that iso-osmolar contrast media are superior
to the low-osmolar agents in preventing CIN. In fact, the
contrary has been demonstrated. Furthermore, during
similar conditions of appropriate periprocedural hydra-
tion (extracellular volume expansion) a possible advan-
tage of any iso-osmolar vs. a low-osmolar contrast media
should be, if anything, minimal. Further studies compar-
ing iso- with low-osmolar contrast media in risk patients
are required before any conclusions can be drawn as to
the possible superiority of certain contrast media. In these
requested studies, the importance of well-controlled and
sufficient hydration status cannot be overestimated.
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